These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35530335)

  • 1. Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis.
    Lo CW; Li WM; Ke HL; Chang YH; Wu HC; Chen IA; Lin JT; Huang CY; Chen CH; Tseng JS; Lin WR; Jiang YH; Lee YK; Tsai CY; Chung SD; Hsueh TY; Chiu AW; Jou YC; Cheong IS; Chen YT; Chen JS; Chiang BJ; Yu CC; Lin WY; Wu CC; Chen CS; Weng HY; Tsai YC
    Front Oncol; 2022; 12():843715. PubMed ID: 35530335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group.
    Lin CY; Weng HY; Tai TY; Wu HC; Chen WC; Chen CH; Huang CY; Lo CW; Yu CC; Tsai CY; Wu WC; Jiang YH; Lee YK; Hsueh TY; Chiu AW; Chiang BJ; Huang HC; Chen IA; Chen YT; Lin WY; Wu CC; Tsai YC; Lee HY; Li WM
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort.
    Matsunaga T; Komura K; Hashimoto T; Muraoka R; Satake N; Tsutsumi T; Tsujino T; Yoshikawa Y; Takai T; Minami K; Taniguchi K; Tanaka T; Uehara H; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
    World J Urol; 2020 Dec; 38(12):3183-3190. PubMed ID: 32065276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
    Ye J; Wang X; Liao X; Chen Z; Wang X; Zhang C; Han P; Wei Q; Bao Y
    Urol Oncol; 2024 Mar; 42(3):69.e1-69.e9. PubMed ID: 38151426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: Competing Risk Analysis after Propensity Score-Matching.
    Kang M; Yoo H; Kim K; Sung SH; Jeon HG; Park SH; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Cancer; 2019; 10(27):6896-6902. PubMed ID: 31839824
    [No Abstract]   [Full Text] [Related]  

  • 11. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
    Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
    Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy.
    Miyake M; Iida K; Nishimura N; Inoue T; Matsumoto H; Matsuyama H; Fujiwara Y; Komura K; Inamoto T; Azuma H; Yasumoto H; Shiina H; Yonemori M; Enokida H; Nakagawa M; Fukuhara H; Inoue K; Yoshida T; Kinoshita H; Matsuda T; Fujii T; Fujimoto K;
    Eur Urol Open Sci; 2022 Jul; 41():95-104. PubMed ID: 35813249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.
    Fujita K; Taneishi K; Inamoto T; Ishizuya Y; Takada S; Tsujihata M; Tanigawa G; Minato N; Nakazawa S; Takada T; Iwanishi T; Uemura M; Okuno Y; Azuma H; Norio N
    BMC Urol; 2017 Dec; 17(1):110. PubMed ID: 29195499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.
    Sakano S; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Kaneda Y; Nasu T; Baba Y; Shimabukuro T; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Oba K;
    Int J Clin Oncol; 2015 Apr; 20(2):362-8. PubMed ID: 24964974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort Study.
    Hongda Z; Kang L; Ng CF; de la Rosette J; Laguna P; Gontero P; Baard J; Yildiz O; Teoh JY
    Bladder Cancer; 2023; 9(3):217-226. PubMed ID: 38993186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
    Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.